...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of stroke and cerebrovascular diseases: The official journal of National Stroke Association >The Use of Oral Anticoagulants in Patients with Atrial Fibrillation in the Emergency Department
【24h】

The Use of Oral Anticoagulants in Patients with Atrial Fibrillation in the Emergency Department

机译：在急诊部中的心房颤动患者中使用口腔抗凝血剂

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Background and aim: Atrial Fibrillation is the leading cause of embolic stroke, yet less than half of high-risk patients with atrial fibrillation are on adequate stroke prevention with oral anticoagulants. Guidelines for the primary prevention of stroke recognize the emergency department as a location for physicians to identify atrial fibrillation and initiate anticoagulants. We sought to compare anticoagulant prescription rates in patients with atrial fibrillation in various provider settings to identify opportunities for improvement in cardioembolic stroke prevention. Methods: A retrospective cohort study of 436 patients with atrial fibrillation presenting to the emergency department from 2014 to 2018 was performed. Baseline characteristics, stroke risk, and rates of anticoagulant prescription were compared across 3 groups: (1) patients discharged from the emergency department, (2) patients admitted under observation status, and (3) patients admitted to inpatient hospital service. Results: Among 436 patients (47% women, 51% Hispanic), we identified 105 in the emergency department cohort, 131 in the observation cohort and 200 in the inpatient cohort. The average CHA(2)DS(2)-VASc score was 2.5 in the emergency department cohort, 2.6 in the observation cohort and 3.3 in the inpatient cohort. Anticoagulants were prescribed for high-risk patients (CHA(2)DS(2)-VASc score > 2) in 17.5% (7/40) of the emergency department cohort compared to 73% (38/52, P< .0001) of the observation cohort and 80% (82/103 P< .0001) of the inpatient cohort. Conclusion: Patients with atrial fibrillation are more likely to be prescribed anticoagulants if admitted to inpatient or under observation status compared to the emergency department.
机译：背景与目的：心房颤动是栓塞性卒中的主要原因，但不到一半的心房颤动高危患者使用口服抗凝剂进行充分的卒中预防。中风一级预防指南承认急诊室是医生识别心房颤动和开始抗凝治疗的场所。我们试图比较不同医疗机构中房颤患者的抗凝剂处方率，以确定改善心源性卒中预防的机会。方法：对2014年至2018年急诊室就诊的436例心房颤动患者进行回顾性队列研究。比较3组患者的基线特征、中风风险和抗凝剂处方率：（1）从急诊室出院的患者，（2）在观察状态下入院的患者，以及（3）住院的患者。结果：在436名患者中（47%为女性，51%为西班牙裔），我们确定急诊队列中有105名患者，观察队列中有131名患者，住院队列中有200名患者。急诊组的平均CHA（2）DS（2）-VASc评分为2.5分，观察组为2.6分，住院组为3.3分。在急诊科队列中，17.5%（7/40）的高危患者（CHA（2）DS（2）-VASc评分>2）服用了抗凝剂，而在观察队列中，这一比例为73%（38/52，P<0.0001），在住院队列中，这一比例为80%（82/103，P<0.0001）。结论：与急诊室相比，房颤患者在住院或观察状态下更有可能服用抗凝剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号